Incorporating data collected in interviews with leading Australian clinical researchers, the Resource Map has identified five key areas in the research development pipeline that could accelerate, expand, and increase the impact of Australian type 1 diabetes clinical research.
The five key opportunities identified which will accelerate clinical research progress are:
- Invest in innovative new ideas and emerging researchers
- Accelerate in research translation from the laboratory to clinical trials
- Establish targeted clinical research funding schemes
- Connect Australian clinical research resources and infrastructure
- Build targeted partnerships and collaborations with global networks and industry
Importantly, the Resource Map has revealed that Australia has a rich resource of a range of sophisticated clinical research tools, but that they are fragmented across research institutions, and so often underutilised. There is a key opportunity for maximising the use of these existing resources through investment into infrastructure that will enable resources to be connected and shared. Enhancing researcher access to these vital tools and resources will maximize investment into clinical research and pave the way for accelerated research progress and faster outcomes for people living with type 1 diabetes.
Welcoming the Resource Map last week, The Minister for Health Sussan Ley said: “The Type 1 Diabetes Clinical Research Resource Map, a collaboration between the Macquarie Group Foundation and JDRF Australia, is a ground-breaking resource that will enhance access to available resources by increasing their visibility, and support a national effort to enable Australian researchers to share and access the resources that are available in Australia, including databases, biobanks, and patient pools.”